MedTrace Logo

The Effect of Colistin Inhalation on Ventilator Associated Pneumonia

NCT03622450 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-08-09

No results posted yet for this study

Summary

The study has been conducted to measure the clinical outcome of early intervention with colistin inhalation in patients with ventilator associated pneumonia suspected to have multidrug resistant gram -ve bacteria

Conditions

  • Ventilator Associated Pneumonia

Interventions

DRUG

Colistin

Polymyxins are bactericidal drugs that bind to lipopolysaccharides (LPS) and phospholipids in the outer cell membrane of gram-negative bacteria.

DRUG

Carbapenem + Aminoglycoside/ Quinolone

Dual antipseudomonal given as IV for ventilator associated pneumonia for patients with Multi-drug resistant bacteria risk factors

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Nourhan Hassan Osama Thuraya Mohamed

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-02
Primary Completion
2018-01-06
Completion
2018-01-10

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03622450 on ClinicalTrials.gov